𝔖 Bobbio Scriptorium

✦ LIBER ✦

Adding mitomycin to other active chemotherapy agents does not improve survival in people with non-small cell lung cancer

✍ Scribed by Raymond P. Abratt

Book ID: 114483803
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 142 KB
Volume: 2
Category: Article
ISSN: 1363-4054
DOI: 10.1054/ebon.2001.0147

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined chemotherapy and radiotherapy d

Combined chemotherapy and radiotherapy does not seem to reduce recurrence or improve survival compared to radiotherapy alone in people with non-small cell lung cancer

✍ Virginie Westeel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Adding paclitaxel to supportive care see

Adding paclitaxel to supportive care seems to improve survival and delay time to progression in people with non-small cell lung cancer

✍ Raymond Abratt 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Adjuvant UFT therapy does not increase s

Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer

✍ Lesley Stewart; Sarah Burdett 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Gefitinib does not improve survival when

Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer: Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.

✍ W.K. (Bill) Evans 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Gefitinib does not improve survival when

Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer: Abstracted from: Giaccone G, Herbst RS, Manegold C et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 1. J Clin Oncol 2004;22:777–784.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Answer to comments on “Survival improvem

Answer to comments on “Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.” by Berghmans T., et al. [Lung Cancer 49 (2005) 13–23]

✍ Berghmans, T.; Paesmans, M.; Sculier, J.P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB